ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $673,000 | +21.0% | 164,035 | +5.5% | 0.00% | – |
| Q4 2021 | $556,000 | -6.6% | 155,471 | -4.8% | 0.00% | – |
| Q3 2021 | $595,000 | -12.8% | 163,377 | +4.6% | 0.00% | – |
| Q2 2021 | $682,000 | +24.9% | 156,257 | +17.7% | 0.00% | – |
| Q1 2021 | $546,000 | -26.5% | 132,747 | -28.7% | 0.00% | – |
| Q4 2020 | $743,000 | +101.9% | 186,252 | +36.4% | 0.00% | – |
| Q3 2020 | $368,000 | +11.2% | 136,520 | +13.3% | 0.00% | – |
| Q2 2020 | $331,000 | +71.5% | 120,525 | +48.0% | 0.00% | – |
| Q1 2020 | $193,000 | -66.4% | 81,424 | -33.4% | 0.00% | – |
| Q4 2019 | $574,000 | +100.7% | 122,202 | +42.7% | 0.00% | – |
| Q3 2019 | $286,000 | -15.9% | 85,641 | -16.9% | 0.00% | – |
| Q2 2019 | $340,000 | +38.2% | 103,098 | +27.7% | 0.00% | – |
| Q1 2019 | $246,000 | +22.4% | 80,720 | +9.0% | 0.00% | – |
| Q4 2018 | $201,000 | +109.4% | 74,036 | +97.8% | 0.00% | – |
| Q2 2018 | $96,000 | -13.5% | 37,436 | -25.7% | 0.00% | – |
| Q1 2018 | $111,000 | +35.4% | 50,417 | +21.7% | 0.00% | – |
| Q4 2017 | $82,000 | -73.1% | 41,433 | -55.9% | 0.00% | – |
| Q3 2017 | $305,000 | +208.1% | 94,041 | +208.9% | 0.00% | – |
| Q2 2017 | $99,000 | -32.2% | 30,444 | -40.9% | 0.00% | – |
| Q1 2017 | $146,000 | -74.2% | 51,532 | -90.4% | 0.00% | -100.0% |
| Q2 2016 | $565,000 | +2873.7% | 537,318 | +2360.2% | 0.00% | – |
| Q1 2016 | $19,000 | -53.7% | 21,840 | -35.7% | 0.00% | – |
| Q4 2015 | $41,000 | -74.2% | 33,945 | -63.8% | 0.00% | – |
| Q3 2015 | $159,000 | -50.0% | 93,715 | -38.7% | 0.00% | – |
| Q2 2015 | $318,000 | +160.7% | 152,904 | +236.7% | 0.00% | – |
| Q1 2015 | $122,000 | -49.6% | 45,412 | -51.8% | 0.00% | – |
| Q4 2014 | $242,000 | +146.9% | 94,209 | +76.4% | 0.00% | – |
| Q3 2014 | $98,000 | -83.6% | 53,421 | -76.1% | 0.00% | – |
| Q2 2014 | $599,000 | -4.2% | 223,609 | +25.2% | 0.00% | -100.0% |
| Q1 2014 | $625,000 | +3.6% | 178,639 | +32.6% | 0.00% | 0.0% |
| Q4 2013 | $603,000 | +15.5% | 134,766 | +4.9% | 0.00% | 0.0% |
| Q3 2013 | $522,000 | +327.9% | 128,495 | +337.2% | 0.00% | – |
| Q2 2013 | $122,000 | -48.5% | 29,388 | -55.5% | 0.00% | – |
| Q1 2013 | $237,000 | – | 66,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |